1-5 of 5
Evgeniy Eruslanov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A016: Selective delivery of fibroblast activation protein conjugated dual phosphoinositide 3-kinase–AKT Kinase-mTOR inhibitor associated with decreased tumor proliferation and on-target toxicity in high-grade soft-tissue sarcomas

Feredun Azari, Gregory T. Kennedy, Ashley Chang, Bilal Nadeem, Azra Din, Isvita Marfatia, Steven Albelda, Philip Low, Madduri Srinivasarao, Ramesh Mukkamala, Neil T. Sullivan, Evgeniy Eruslanov, Sunil Singhal
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18_Supplement): A016.
https://doi.org/10.1158/1557-3265.SARCOMAS22-A016
Published: 15 September 2022
View article titled, Abstract A016: Selective delivery of fibroblast activation protein conjugated dual phosphoinositide 3-kinase–AKT Kinase-mTOR inhibitor associated with decreased tumor proliferation and on-target toxicity in high-grade soft-tissue sarcomas
Journal Articles

A Cathepsin-Targeted Quenched Activity–Based Probe Facilitates Enhanced Detection of Human Tumors during Resection

Gregory T. Kennedy, David E. Holt, Feredun S. Azari, Elizabeth Bernstein, Bilal Nadeem, Ashley Chang, Neil T. Sullivan, Alix Segil, Charuhas Desphande, Eric Bensen, John T. Santini, Jr, John C. Kucharczuk, Edward J. Delikatny, Matthew Bogyo, A.J. Matthew Egan, Charles W. Bradley, Evgeniy Eruslanov, Jason D. Lickliter, Gavin Wright, Sunil Singhal
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (17): 3729–3741.
https://doi.org/10.1158/1078-0432.CCR-22-1215
Published: 01 September 2022
View article titled, A Cathepsin-Targeted Quenched Activity–Based Probe Facilitates Enhanced Detection of Human Tumors during Resection
Open the PDF for A Cathepsin-Targeted Quenched Activity–Based Probe Facilitates Enhanced Detection of Human Tumors during Resection in another window
Includes: Supplementary data
Journal Articles

Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer

Edmund K. Moon, Raghuveer Ranganathan, Evgeniy Eruslanov, Soyeon Kim, Kheng Newick, Shaun O'Brien, Albert Lo, Xiaojun Liu, Yangbing Zhao, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2): 436–447.
https://doi.org/10.1158/1078-0432.CCR-15-1070
Published: 14 January 2016
View article titled, Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer
Open the PDF for Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer in another window
Includes: Supplementary data
Journal Articles

Expansion of CCR8+ Inflammatory Myeloid Cells in Cancer Patients with Urothelial and Renal Carcinomas

Evgeniy Eruslanov, Taryn Stoffs, Wan-Ju Kim, Irina Daurkin, Scott M. Gilbert, Li-Ming Su, Johannes Vieweg, Yehia Daaka, Sergei Kusmartsev
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (7): 1670–1680.
https://doi.org/10.1158/1078-0432.CCR-12-2091
Published: 02 April 2013
View article titled, Expansion of CCR8<sup>+</sup> Inflammatory Myeloid Cells in Cancer Patients with Urothelial and Renal Carcinomas
Open the PDF for Expansion of CCR8<sup>+</sup> Inflammatory Myeloid Cells in Cancer Patients with Urothelial and Renal Carcinomas in another window
Includes: Supplementary data
Journal Articles

Reversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma

Sergei Kusmartsev, Zhen Su, Axel Heiser, Jens Dannull, Evgeniy Eruslanov, Hubert Kübler, Donna Yancey, Philip Dahm, Johannes Vieweg
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 8270–8278.
https://doi.org/10.1158/1078-0432.CCR-08-0165
Published: 15 December 2008
View article titled, Reversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
Open the PDF for Reversal of Myeloid Cell–Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma in another window